Median survival time for HRS-AKI is 2 weeks and for HRS-NAKI is 6 months.[20]Gines P, Guevara M, Arroyo V, et al. Hepatorenal syndrome. Lancet. 2003 Nov 29;362(9398):1819-27.
http://www.ncbi.nlm.nih.gov/pubmed/14654322?tool=bestpractice.com
[49]Guevara M, Ginès P. Hepatorenal syndrome. Dig Dis. 2005;23(1):47-55.
https://www.karger.com/Article/Pdf/84725
http://www.ncbi.nlm.nih.gov/pubmed/15920325?tool=bestpractice.com
One systematic review and meta-analysis that included 14 randomised controlled trials (conducted between 2002 and 2018) reported a pooled survival rate of 34.6% among patients with HRS-AKI.[50]Thomson MJ, Taylor A, Sharma P, et al. Limited progress in hepatorenal syndrome (HRS) reversal and survival 2002-2018: a systematic review and meta-analysis. Dig Dis Sci. 2020 May;65(5):1539-48.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103565
http://www.ncbi.nlm.nih.gov/pubmed/31571102?tool=bestpractice.com